openPR Logo
Press release

Patient Engagement Solutions Market is Expected to Reach USD 59.4 Billion by 2032| DelveInsight

10-31-2025 03:09 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Patient Engagement Solutions Market

Patient Engagement Solutions Market

The global Patient Engagement Solutions Market is poised for robust growth, projected to soar from USD 23,880.95 million in 2024 to an impressive USD 59,499.28 million by 2032. This surge is driven by a compelling CAGR of 12.15% during the forecast period from 2025 to 2032, fueled primarily by the rising prevalence of chronic diseases and accelerating technological innovations in healthcare delivery.

Explore how cutting-edge patient engagement solutions can improve outcomes and optimize care coordination in your organization - https://www.delveinsight.com/report-store/patient-engagement-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Patient Engagement Solutions Market Drivers and Dynamics
Chronic diseases such as diabetes, cardiovascular disorders, and obesity are reaching unprecedented levels worldwide, catalyzing the demand for advanced patient engagement technologies. According to the British Heart Foundation, approximately 640 million people suffer from heart and circulatory diseases globally as of 2024, with nearly 67 million new diagnoses annually. In parallel, International Diabetes Federation data from 2021 reports over 537 million adults living with diabetes-a figure expected to escalate to 643 million by 2030 and 783 million by 2045. Similarly, projections from the World Obesity Federation estimate that by 2030 nearly one billion people will be affected by obesity.
These alarming statistics underscore the urgent need for continuous patient monitoring and engagement solutions that empower patients to manage their health proactively. The global shift toward patient-centered care models further intensifies demand, as evidenced by NHS England reporting over one million patient-physician interactions every 36 hours, with a growing percentage of patients actively involved in care decisions. Surveys like that of the Canadian Medical Association validate the rising acceptance of virtual care as a critical component enhancing access and patient engagement worldwide.
Government interventions also play a pivotal role. The World Health Organization's 2024 launch of the Global Initiative on Digital Health exemplifies efforts to foster sustainable digital health transformation, encouraging national adoption of patient engagement platforms critical for improved healthcare outcomes.

Technological Innovations and Product Launches
Technological advancements are reshaping patient engagement. Recent breakthroughs include HSBlox's CureAlign 3.9 platform, featuring Carengage workflow solutions to enhance care coordination within value-based care frameworks. PatientPoint's PatientPoint FocusTM platform offers tailored patient information throughout the care continuum, promoting informed discussions and proactive health management. These innovations exemplify the expanding capabilities and market penetration of patient engagement software.
Software solutions dominate the product segment, buoyed by the increased adoption of telehealth and digital home care services. For instance, the Australian Health Practitioner Regulation Agency reported that over 25% of Australians engaged in telehealth consultations within a 12-month span in 2024. Similarly, NHS England statistics reveal nearly half a million individuals benefited from digital home care and remote monitoring technologies between 2020 and 2023.

Deployment and End-User Segmentation
Cloud-based deployments are gaining traction due to their scalability and remote accessibility, while on-premise solutions maintain a foothold among healthcare providers valuing data control. Hospitals and clinics remain the largest end-users, but home healthcare segments are rapidly expanding, reflecting a global pivot toward decentralized patient engagement initiatives.

Download Our Free Market Insights Report! Gain exclusive access to the latest trends and growth opportunities in the patient engagement solutions market - https://www.delveinsight.com/sample-request/patient-engagement-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Patient Engagement Solutions Geographic Outlook
North America leads the global Patient Engagement Solutions market share, driven by a high chronic disease burden, early telehealth adoption, and supportive regulatory frameworks. According to CDC 2024 data, 4.9% of U.S adults were diagnosed with coronary heart disease, while over 29 million suffer from diabetes. Telemedicine is increasingly prevalent, with 37% of American adults using such services in the past year. Canadian health authorities report similar trends, further bolstering regional market demand.

Europe and Asia-Pacific follow closely, with Europe's well-established healthcare systems and favorable reimbursements facilitating significant growth, while Asia-Pacific benefits from rising cardiovascular disease prevalence, aging demographics, and burgeoning telehealth adoption. Notably, Japan's PMDA-approved AI-enabled ECG monitoring innovations spotlight the region's technological strides.

Learn from industry experts about leveraging digital health platforms to drive patient-centered care and operational efficiency - https://www.delveinsight.com/sample-request/patient-engagement-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Patient Engagement Solutions Competitive Landscape and Strategic Developments
Key industry players actively shaping the patient engagement ecosystem include McKesson Corporation, Oracle, Phreesia, OSP Labs, Veradigm LLC, athenahealth, GetWellNetwork, Medisafe, Personify Health, CipherHealth, and numerous others. Noteworthy initiatives include the June 2024 strategic partnership between Personify Care and Novari Health, enhancing patient engagement across Canada and the UK, as well as Pada Health's May 2024 comprehensive Patient Engagement Platform launch.

Patient Engagement Solutions Market Challenges and Future Outlook
While growth prospects are robust, critical challenges such as data privacy concerns, cybersecurity risks, and substantial implementation costs persist. Addressing these effectively will be essential to unlocking the full potential of patient engagement technologies.

The Patient Engagement Solutions Market embodies a transformative force in healthcare delivery, balancing technological innovation with evolving patient expectations and systemic healthcare reforms. Stakeholders prioritizing patient-centric strategies, digital integration, and collaborative innovation are positioned to capitalize on this expanding market opportunity through 2032.

Speak with our digital health experts to discover how patient engagement solutions can transform your healthcare delivery and improve patient outcomes - https://www.delveinsight.com/sample-request/patient-engagement-solution-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Patient Engagement Solutions Market is Expected to Reach USD 59.4 Billion by 2032| DelveInsight here

News-ID: 4247687 • Views: …

More Releases from DelveInsight Business Research

Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by 240,000+ Diagnosed Cases Across 7MM, estimates DelveInsight
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Therapies, estimates DelveInsight
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others. DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerated Expansion, Fueled by Targeted Therapies and a Growing Innovation Pipeline, Says DelveInsight
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue. The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs…
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Companies Reshaping the Treatment Landscape, estimates DelveInsight
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets. Explore the…

All 5 Releases


More Releases for Patient

How Patient Monitors Improve Patient Safety and Healthcare Efficiency
Image: https://www.yonkermed.com/uploads/%E6%9C%AA%E6%A0%87%E9%A2%98-150.png In today's fast-paced clinical environments, ensuring patient safety while maintaining high levels of efficiency is one of the greatest challenges faced by healthcare providers. Hospitals and medical institutions must manage increasing patient volumes, complex clinical conditions, and limited medical resources. In this context, patient monitors [https://www.yonkermed.com/patient-monitors/] have become essential tools that significantly enhance both patient safety and healthcare efficiency. Often considered the technological backbone of modern clinical care, patient monitors…
Patient Care Advocacy Market Is Going to Boom |• Patient Advocate Foundation â …
Worldwide Market Reports has added a new research study on "Patient Care Advocacy Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources. The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development…
Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Patient Portal Market: Empowering Patient-Centric Healthcare
In recent years, the global Patient Portal Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Patient Portal Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
10-11-2022 | Health & Medicine
Fact.MR
Growing Demand For Patient Handling Equipment & Patient Positioning Devices To A …
As per Fact.MR, a market research and competitive intelligence provider, the global patient lateral transfer devices market is anticipated to top US$ 500 Mn by 2031, progressing at a CAGR of 7% over the forecast period of 2021 to 2031. Lateral transfer is a repositioning aid or equipment that reduces friction and makes it easier and safer to transfer patients laterally. Patient lateral transfer devices are designed to stay with the…
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, But Imp …
GBI Research, the leading business intelligence provider, has released its latest research, Patient Perspectives Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge. The report examines the role of patients in changing the research agenda and helping pharma companies to bring effective medicines that meet real unmet medical needs into the market place. It explores the use of patient reported outcomes in drug development, with a…